Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2020

May 1, 2020

29831_dirs_2020-05-01_6eaa8a81-f062-414c-abc8-bc984fe23e5f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-04-29

Reporting Person: ROGERS DAWN (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-29 Common Stock S 13000.0000 $38.1300 Disposed 4823.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-30 Phantom Stock Units SSP $ A 52.0000 Acquired Common Stock (52.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9818.0000 Indirect

Footnotes

F1: Each unit represents one phantom share of common stock.

F2: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.